MX9800408A - Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. - Google Patents

Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.

Info

Publication number
MX9800408A
MX9800408A MX9800408A MX9800408A MX9800408A MX 9800408 A MX9800408 A MX 9800408A MX 9800408 A MX9800408 A MX 9800408A MX 9800408 A MX9800408 A MX 9800408A MX 9800408 A MX9800408 A MX 9800408A
Authority
MX
Mexico
Prior art keywords
salts
cyclo
pharmaceutical compositions
compositions containing
drugs
Prior art date
Application number
MX9800408A
Other languages
English (en)
Other versions
MXPA98000408A (es
Inventor
Pierre-Etienne Cha Lassauniere
Colette Broquet
Original Assignee
Conseils De Rech S Et Soc D
Aplications Scient D
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conseils De Rech S Et Soc D, Aplications Scient D, Scras filed Critical Conseils De Rech S Et Soc D
Publication of MXPA98000408A publication Critical patent/MXPA98000408A/es
Publication of MX9800408A publication Critical patent/MX9800408A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

La presente invencion es concerniente con sales de derivados de amidina y del inhibidor de la ciclooxigenasa, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y su uso particular como inhibidores de la NO-sintasa y ciclooxigenasa.
MX9800408A 1995-07-15 1996-07-15 Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. MX9800408A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9514518.1A GB9514518D0 (en) 1995-07-15 1995-07-15 Guanidine salt inhibitors of NO synthase and cyclooxygenase
GB9514518.1 1995-07-15
PCT/FR1996/001095 WO1997003678A1 (fr) 1995-07-15 1996-07-15 Sels de derives d'amidine et d'inhibiteur de cyclooxygenase, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
MXPA98000408A MXPA98000408A (es) 1998-04-01
MX9800408A true MX9800408A (es) 1998-04-30

Family

ID=10777740

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9800408A MX9800408A (es) 1995-07-15 1996-07-15 Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.

Country Status (24)

Country Link
US (1) US6063807A (es)
EP (1) EP0839041B1 (es)
JP (1) JPH11509540A (es)
CN (1) CN1187056C (es)
AT (1) ATE264107T1 (es)
AU (1) AU704373B2 (es)
CA (1) CA2227034A1 (es)
CZ (1) CZ293676B6 (es)
DE (1) DE69632193T2 (es)
DK (1) DK0839041T3 (es)
ES (1) ES2219690T3 (es)
GB (1) GB9514518D0 (es)
HU (1) HUP9901331A3 (es)
IL (1) IL122737A (es)
MX (1) MX9800408A (es)
NO (1) NO980178L (es)
NZ (1) NZ313654A (es)
PL (1) PL185375B1 (es)
PT (1) PT839041E (es)
RU (1) RU2167856C2 (es)
TW (1) TW474908B (es)
UA (1) UA53624C2 (es)
WO (1) WO1997003678A1 (es)
ZA (1) ZA965969B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925351A (en) 1995-07-21 1999-07-20 Biogen, Inc. Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US7255854B1 (en) 1996-10-25 2007-08-14 Biogen, Inc. Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases
SK12672001A3 (sk) * 1999-12-08 2002-04-04 Pharmacia Corporation Zloženia inhibítora cyklooxygenázy-2 s rýchlym nástupom terapeutického účinku
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
AU7090201A (en) 2000-07-20 2002-02-05 Lauras As Method
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
MY137736A (en) 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition
UA80682C2 (en) * 2001-08-06 2007-10-25 Pharmacia Corp Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
WO2003088959A2 (en) * 2002-04-18 2003-10-30 Pharmacia Corporation Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
AU2003223579A1 (en) * 2002-04-18 2003-11-03 Pharmacia Corporation Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
EP2311481A3 (en) 2006-10-20 2013-10-16 Biogen Idec MA Inc. Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
US20090155430A1 (en) * 2007-12-14 2009-06-18 E.I. Du Pont De Nemours And Company Films comprising liquid smoke and flavorants
RU2478618C2 (ru) * 2010-03-15 2013-04-10 Закрытое Акционерное Общество "Инфарма" Новое биологически активное соединение n-[3-(4-нитрофениламино)-индол-2-илметилен] аминогуанидина гидрохлорид с противовоспалительной активностью
RU2480452C1 (ru) * 2012-01-11 2013-04-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургская государственная химико-фармацевтическая академия" Министерства здравоохранения Российской Федерации (ГБОУ ВПО СПХФА Минздрава России) Способ получения n-4-нитрофенилбензамидина
RU2684117C1 (ru) * 2018-10-29 2019-04-04 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный химико-фармацевтический университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России) Способ получения N-(нафталин-2-ил)бензамидина
CN109678715B (zh) * 2018-11-28 2019-11-12 中国药科大学 2-(1-酰氧正戊基)苯甲酸与碱性氨基酸或氨基胍形成的盐、其制备方法及用途
RU2694263C1 (ru) * 2019-02-14 2019-07-11 Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный химико-фармацевтический университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России) Анальгезирующее и противовоспалительное средство с противомикробной активностью

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56147761A (en) * 1980-04-15 1981-11-16 Banyu Pharmaceut Co Ltd Salt compound consisting of acetylsalicylic acid and diguanidine, its preparation and agent containing the same as active constitutent
US4324801A (en) * 1981-04-21 1982-04-13 Banyu Pharmaceutical Co. Ltd. Phenylguanidine acetylsalicylate compounds, process for production thereof, and pharmaceutical composition thereof
JPS61143320A (ja) * 1985-11-08 1986-07-01 Banyu Pharmaceut Co Ltd 微小循環器系改善剤
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase

Also Published As

Publication number Publication date
ZA965969B (en) 1997-10-31
HUP9901331A3 (en) 1999-11-29
ATE264107T1 (de) 2004-04-15
CN1190890A (zh) 1998-08-19
RU2167856C2 (ru) 2001-05-27
US6063807A (en) 2000-05-16
IL122737A (en) 2003-01-12
PL185375B1 (pl) 2003-04-30
TW474908B (en) 2002-02-01
NO980178D0 (no) 1998-01-14
DE69632193T2 (de) 2005-05-04
WO1997003678A1 (fr) 1997-02-06
HUP9901331A2 (hu) 1999-08-30
UA53624C2 (uk) 2003-02-17
DK0839041T3 (da) 2004-08-09
ES2219690T3 (es) 2004-12-01
NO980178L (no) 1998-01-14
EP0839041A1 (fr) 1998-05-06
GB9514518D0 (en) 1995-09-13
AU6617596A (en) 1997-02-18
CN1187056C (zh) 2005-02-02
CA2227034A1 (fr) 1997-02-06
EP0839041B1 (fr) 2004-04-14
PT839041E (pt) 2004-09-30
PL324490A1 (en) 1998-05-25
NZ313654A (en) 1999-10-28
IL122737A0 (en) 1998-08-16
CZ293676B6 (cs) 2004-06-16
AU704373B2 (en) 1999-04-22
DE69632193D1 (de) 2004-05-19
CZ7398A3 (cs) 1998-06-17
JPH11509540A (ja) 1999-08-24

Similar Documents

Publication Publication Date Title
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
HUP0200355A3 (en) 4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use
AU4308397A (en) Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
ZA973647B (en) Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them.
TR199800077T1 (xx) Kontroll� ��z�len paroksetin terkipleri.
HUP0003311A2 (en) Substituted 6-phenylphenanthridine derivatives, pocess for producing them and pharmaceutical compositions containing them
AU7294098A (en) Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
HUP9900056A2 (hu) Szubsztituált 4-fenil-amino-tiazol-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
NO984290L (no) Farmas°ytisk nyttige forbindelser
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
HUP9903492A2 (en) Quinoline derivatives as type iv phosphodiesterase inhibitors, process for their preparation, pharmaceutical compositions containing the same and their use
HUP9900071A3 (en) Tribenzimidazoles useful as topoisomerase i inhibitors, pharmaceutical compositions containing them and their use
AU3901393A (en) Biphenylylquinuclidine derivatives as squalene synthase inhibitors
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
ZA974033B (en) Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors.
HUP0204135A3 (en) Arnesyl transferase inhibitors, process for their preparation and pharmaceutical compositions containing them
ZA963744B (en) Topical aciclovir preparation
ZA9811787B (en) Novel farnesyl transferase inhibitors, their preparation, pharmaceutical compositions which contain them and their use for the preparation of medicaments.
IL117302A (en) Cryptophycin derivatives, methods for the production thereof and pharmaceutical compositions containing the same
JO1880B1 (en) Format 1 for multi-unit calibration discs
HUP0003500A3 (en) Cyclopeptide derivatives as adhesion inhibitors, pharmaceutical composition containing thereof, process for production thereof and their use

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees